Should You Buy Immutep Ltd (IMMP) Today? Analysis, Price Targets, and 2026 Outlook.
No data
No data
Growth
Profitability
Efficiency
Wall Street analysts forecast IMMP stock price to rise
1 Analyst Rating
Wall Street analysts forecast IMMP stock price to rise
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 0.432
Low
12
Averages
12
High
12
Current: 0.432
Low
12
Averages
12
High
12
Maxim
Maxim
Buy -> Hold
downgrade
AI Analysis
2026-03-13
Reason
Maxim
Maxim
Price Target
AI Analysis
2026-03-13
downgrade
Buy -> Hold
Reason
Maxim downgraded Immutep (IMMP) to Hold from Buy after the company's Phase 3 study with Merck (MRK) of eftilagimod alfa in patients in first line non-small cell lung cancer was halted for futility.
Citizens
Reni Benjamin
Outperform -> Market Perform
downgrade
2026-03-13
Reason
Citizens
Reni Benjamin
Price Target
2026-03-13
downgrade
Outperform -> Market Perform
Reason
Citizens analyst Reni Benjamin downgraded Immutep to Market Perform from Outperform without a price target. The firm cites the discontinuation of the company's lead program for the downgrade. The analyst expects the shares to trade inline with the market until randomized study results are reported.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for IMMP
